Oct 1 |
PureTech to Present at CHEST 2024 Annual Meeting
|
Sep 30 |
FDA approves PureTech’s KarXT to treat schizophrenia in adults
|
Sep 27 |
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
|
Sep 6 |
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
|
Sep 3 |
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
|
Aug 28 |
PureTech Health plc (PRTC) Q2 2024 Earnings Call Transcript
|
Aug 28 |
PureTech reports 1H results
|
Aug 28 |
PureTech Health plc – Half-Year Report
|
Aug 22 |
PureTech Appoints Michele Holcomb, PhD, to Board of Directors
|
Aug 21 |
PureTech Health: Notice of Half-Yearly Results
|